Old CIC Events
08/04/2021
Role of C3G in megakaryopoiesis, hypoxia-induced angiogenesis and melanoma metastasis.
Luis Hernández — Centro de Investigación del Cáncer (CIC-IBMCC)
25/03/2021
HER-3 targeting with an antibody-drug conjugate
Lucía Gandullo — Centro de Investigación del Cáncer (CIC-IBMCC, Universidad de Salamanca-CSIC)
18/03/2021
Machine Learning in cardiovascular research: integrating molecular and phenotypical information in large cohort studies
Fátima Sánchez Cabo — CNIC, Madrid
11/03/2021
Targeting anti-apoptotic proteins in multiple myeloma
Mercedes Garayoa — Centro de Investigación del Cáncer (CIC-IBMCC)
04/03/2021
Challenges in breast cancer treatment: understanding the actions and effectiveness of anti-ER drugs
Antoni Hurtado — Universidad de Barcelona, Spain
25/02/2021
Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair
María Ovejero Sánchez — Centro de Investigación del Cáncer (CIC-IBMCC)
18/02/2021
Genetic tuning of actin remodelling at the plasma membrane
Klemens Rottner — Division of Molecular Cell Biology del Zoological Institute/Technische Universität Braunschweig (Braunschweig, Germany )
11/02/2021
Commensal gut microbiota protects genetically predisposed mice against acute lymphoblastic leukaemia
Carolina Vicente-Dueñas — Centro de Investigación del Cáncer (CIC-IBMCC)
04/02/2021
Combination Therapies to Potentiate the Impact of KRAS-G12C Inhibitors
Miriam Molina Arcas — Oncogene Biology Laboratory, Francis Crick Institute, London, UK
21/01/2021
Twists and turns in the development of CD137 (4-1BB)-based immunotherapy
Ignacio Melero Bermejo — Clínica Universidad de Navarra / Centro de Investigación Médica Aplicada (CIMA) de Pamplona
14/01/2021
Sensing from the inside: how the nucleus controls adaptive cell responses to shape deformations
Verena Ruprecht — Centre for Genomic Regulation (CRG) de Barcelona